These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32336832)

  • 1. Imaging methods in the assessment of nonalcoholic fatty liver disease.
    Parente DB
    Radiol Bras; 2020; 53(2):IX-X. PubMed ID: 32336832
    [No Abstract]   [Full Text] [Related]  

  • 2. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee.
    Loria P; Adinolfi LE; Bellentani S; Bugianesi E; Grieco A; Fargion S; Gasbarrini A; Loguercio C; Lonardo A; Marchesini G; Marra F; Persico M; Prati D; Baroni GS;
    Dig Liver Dis; 2010 Apr; 42(4):272-82. PubMed ID: 20171943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease and cardiovascular disease phenotypes.
    Bisaccia G; Ricci F; Mantini C; Tana C; Romani GL; Schiavone C; Gallina S
    SAGE Open Med; 2020; 8():2050312120933804. PubMed ID: 32612827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raman imaging of rat nonalcoholic fatty liver tissues reveals distinct biomolecular states.
    Helal KM; Cahyadi H; Taylor JN; Okajima A; Tabata K; Kumamoto Y; Mochizuki K; Itoh Y; Takamatsu T; Tanaka H; Fujita K; Komatsuzaki T; Harada Y
    FEBS Lett; 2023 Jun; 597(11):1517-1527. PubMed ID: 36807196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging for the assessment of pathological hepatic findings in nonalcoholic fatty liver disease.
    Imajo K; Honda Y; Yoneda M; Saito S; Nakajima A
    J Med Ultrason (2001); 2020 Oct; 47(4):535-548. PubMed ID: 33108553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: new trends and role of ultrasonography.
    Tada T; Nishimura T; Yoshida M; Iijima H
    J Med Ultrason (2001); 2020 Oct; 47(4):511-520. PubMed ID: 33089412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of nonalcoholic fatty liver disease using magnetic resonance in obese children and adolescents.
    Benetolo PO; Fernandes MIM; Ciampo IRLD; Elias-Junior J; Sawamura R
    J Pediatr (Rio J); 2019; 95(1):34-40. PubMed ID: 29438686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).
    Yoneda M; Yoneda M; Mawatari H; Fujita K; Endo H; Iida H; Nozaki Y; Yonemitsu K; Higurashi T; Takahashi H; Kobayashi N; Kirikoshi H; Abe Y; Inamori M; Kubota K; Saito S; Tamano M; Hiraishi H; Maeyama S; Yamaguchi N; Togo S; Nakajima A
    Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Liver Biopsy Necessary in Patients With Nonalcoholic Fatty Liver Disease?
    Gavril RS; Mihalache L; Arhire L; Grosu C; Gherasim A; Nita O; Oprescu AC; Graur M
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(3):503-7. PubMed ID: 30044567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyridoxamine improves metabolic and microcirculatory complications associated with nonalcoholic fatty liver disease.
    Pereira ENGDS; Silvares RR; Flores EEI; Rodrigues KL; Daliry A
    Microcirculation; 2020 Apr; 27(3):e12603. PubMed ID: 31876010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Could semiquantitative analysis of real-time ultrasound elastography distinguish more liver parenchyma alterations of nonalcoholic fatty liver disease in patients with polycystic ovary syndrome?
    Di N; Zhou X; Chen Y; Zhao X; Li L; Jiang L; Luo B; Chen X; Yang D
    Arch Endocrinol Metab; 2019; 63(2):128-136. PubMed ID: 30916169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life in patients with nonalcoholic fatty liver disease in combination with essential hypertension considering taste sensitivity to sodium chloride.
    Mashura HY; Hanych TM; Rishko AA
    Wiad Lek; 2016; 69(2 Pt 2):204-7. PubMed ID: 27487534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of nonalcoholic fatty liver disease with bone mineral density and serum osteocalcin levels in Korean men.
    Yang HJ; Shim SG; Ma BO; Kwak JY
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):338-44. PubMed ID: 26636404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High coffee intake is associated with lower grade nonalcoholic fatty liver disease: the role of peripheral antioxidant activity.
    Gutiérrez-Grobe Y; Chávez-Tapia N; Sánchez-Valle V; Gavilanes-Espinar JG; Ponciano-Rodríguez G; Uribe M; Méndez-Sánchez N
    Ann Hepatol; 2012; 11(3):350-5. PubMed ID: 22481454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between nonalcoholic fatty liver disease prevalence and visceral fat in obese adolescents.
    Dâmaso AR; do Prado WL; de Piano A; Tock L; Caranti DA; Lofrano MC; Carnier J; Cristofalo DJ; Lederman H; Tufik S; de Mello MT
    Dig Liver Dis; 2008 Feb; 40(2):132-9. PubMed ID: 18082476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients.
    Federico A; Dallio M; Masarone M; Gravina AG; Di Sarno R; Tuccillo C; Cossiga V; Lama S; Stiuso P; Morisco F; Persico M; Loguercio C
    Oxid Med Cell Longev; 2019; 2019():8742075. PubMed ID: 31737175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD-NASH Cohort.
    Troelstra MA; Witjes JJ; van Dijk AM; Mak AL; Gurney-Champion O; Runge JH; Zwirs D; Stols-Gonçalves D; Zwinderman AH; Ten Wolde M; Monajemi H; Ramsoekh S; Sinkus R; van Delden OM; Beuers UH; Verheij J; Nieuwdorp M; Nederveen AJ; Holleboom AG
    J Magn Reson Imaging; 2021 Dec; 54(6):1937-1949. PubMed ID: 33991378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathological findings of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Kage M; Aishima S; Kusano H; Yano H
    J Med Ultrason (2001); 2020 Oct; 47(4):549-554. PubMed ID: 33136250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease: scintigraphy in the diagnosis of steatohepatitis.
    Silva ADD; Mattos ÂZ; Tovo CV; Daros LF; Anselmi OE; Coral GP; Mattos AA
    Rev Assoc Med Bras (1992); 2021 Nov; 67(11):1665-1669. PubMed ID: 34909896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of glucagon-to-insulin ratio and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
    Moh Moh MA; Jung CH; Lee B; Choi D; Kim BY; Kim CH; Kang SK; Mok JO
    Diab Vasc Dis Res; 2019 Mar; 16(2):186-195. PubMed ID: 30428692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.